Estudio comparativo de la premedicación con midazolam y ketamina por vía endovenosa en pacientes pediátricos sometidos a cirugía no cardiaca. Hospital Regional de Loreto 2022

GENERAL OBJECTIVE: To compare premedication with midazolam and ketamine intravenously in pediatric patients undergoing non-cardiac surgery treatment. Regional Hospital of Loreto 2022. MATERIALS AND METHODS: A quantitative, descriptive, analytical, cross-sectional, and retrospective study will be car...

Descripción completa

Detalles Bibliográficos
Autor: Vasquez del Aguila, Luis Bernardo
Tipo de recurso: tesis de maestría
Fecha de publicación:2025
País:Perú
Institución:Universidad Nacional De La Amazonía Peruana
Repositorio:UNAPIquitos-Institucional
Idioma:español
OAI Identifier:oai:repositorio.unapiquitos.edu.pe:20.500.12737/11059
Acceso en línea:https://hdl.handle.net/20.500.12737/11059
Access Level:acceso abierto
Palabra clave:Anestesia intravenosa
Premedicación
Midazolam
Ketamina
Niños
Cirugía general
https://purl.org/pe-repo/ocde/ford#3.02.09
Descripción
Sumario:GENERAL OBJECTIVE: To compare premedication with midazolam and ketamine intravenously in pediatric patients undergoing non-cardiac surgery treatment. Regional Hospital of Loreto 2022. MATERIALS AND METHODS: A quantitative, descriptive, analytical, cross-sectional, and retrospective study will be carried out, because previously made reports will be analyzed. The study population will be all those medical records of pediatric patients undergoing non-cardiac surgery between 2 and 8 years, of both sexes with ASA I and ASA II without respiratory pathologies and fasting after surgery who have received intravenously Midazolam at doses of 0.05 - 0.1 mg / kg or 0,2 – 0,5 mg / kg of ketamine weight, 10 to 15 minutes before the intervention. CONCLUSIONS: There are several drugs to relieve the child's anxiety during the preoperative period. Premedication is a routine act since the emergence of anesthesia and aims to reduce the child's anxiety, reduce anesthetics during surgery, improve the response of the autonomic nervous system and reduce the base metabolism. To date there is little evidence on the drug of choice in the pediatric population, being the most used drugs are Midazolam and Ketamine in our environment, so its evaluation is required.